Automated immuno phenotyping of neutrophils in geriatric hip fracture patients, the AQUIOS study

Automated immuno phenotyping of neutrophils in geriatric hip fracture patients, the AQUIOS study - AQUIOS study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON49050

Enrollment

100

Registered

2021-02-16

Start date

2021-06-14

Completion date

Unknown

Last updated

2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

broken hip hip fracture

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 70 years old or above Subtrochanteric, pertrochanteric, or femoral neck fracture

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
The main study endpoint is reached if the AQUIOS is started 80% of all included patients.	—

Secondary

Measure	Time frame
The secondary endpoints are defined as - a difference in protein expression and/or neutrophil responsiveness between the patients that develop infectious complications and patients who do not. - a difference in pH, PvO2, PvCO2, or HCO3- between the patients that develop infectious complications and patients who do not.	—

Countries

Netherlands

Outcome results